Expression of Ki-67 and KRAS in Bangladeshi Ovarian Cancer Patients Attending a Tertiary Care Cancer Hospital
Keywords:
Ovarian cancer, Ki-67, KRAS, ImmunohistochemistryAbstract
Background: Among several biomarkers Ki-67 and KRAS are two significant biomarkers providing information of biological behavior of ovarian cancer and targeted therapies. In this study the expressions status of Ki-67 and KRAS were assessed and correlated with each other and with the cancer-related characteristics.
Objective: The aim of this study was to assess and correlate the expressions of Ki-67 and KRAS in ovarian cancer patients and analyze the expressions with cancer-related characteristics of the patients. Methods: In this cross-sectional analytical study 30 formalin-fixed paraffin-embedded (FFPE) ovarian cancer tissue blocks and 20 FFPE non-cancerous ovarian tissue blocks were collected and immunohistochemical staining for Ki-67 and KRAS expressions in these tissue sections were done. Cancer-related information of the patients were collected. Immunohistochemical staining for Ki-67 and KRAS were analyzed to assess the expression in ovarian cancer tissues and to observe the association of their expressions with each other and with the cancer-related characteristics.
Results: Expression of Ki-67 was significantly high in cancerous than non-cancerous ovarian tissues and Ki- 67 index was ≥20% in 60% of ovarian cancer tissue. KRAS was expressed in 20% of ovarian cancer tissues and none of the non-cancerous ovarian tissues. Statistically significant association was found between the positive expression of KRAS with pelvic organs and lymph nodes involvement. Expression of Ki-67 and KRAS also significantly associated with each other.
Conclusion: Ki-67 was highly expressed in ovarian cancer tissue than non-cancerous ovarian tissue and Ki- 67 expression was significantly associated with KRAS expression. KRAS expression is significantly associated with pelvic organs and lymph nodes metastases. So, these two markers can be new biomarkers for assessing biological behaviour and progression.
Bangladesh Medical Res Counc Bull 2026;52(2): 78-83
15
12
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sadika Sharmin, Latifa Nishat, Farida Arjuman, Nargis Sultana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms.
Authors retain copyright and grant the journal right of first publication.
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
